platelet transfusion afshan

41
PLATELET TRANSFUSION AFSHAN SHAMIM AFSHAN SHAMIM B.S MT 3 B.S MT 3 RD RD YEAR 6 YEAR 6 TH TH SEMESTER SEMESTER

Upload: zahoor-ahmed

Post on 11-May-2015

5.117 views

Category:

Documents


2 download

TRANSCRIPT

Page 1: Platelet Transfusion Afshan

PLATELET TRANSFUSION

PLATELET TRANSFUSION

AFSHAN SHAMIMAFSHAN SHAMIM

B.S MT 3B.S MT 3RDRD YEAR 6 YEAR 6THTH SEMESTER SEMESTER

Page 2: Platelet Transfusion Afshan

What are platelets?

    Platelets are blood cells that help control bleeding.  When a blood vessel is damaged, platelets collect at the site of injury and temporarily repair the tear.  They then activate substances in plasma which form a clot and allow the wound to heal. 

 

Page 3: Platelet Transfusion Afshan

Plateletpheresis

Plateletpheresis is the process of collecting platelets.

Page 4: Platelet Transfusion Afshan

Types Of Platelets:• Random Donor platelets (RDP) are

prepared from donated blood with in 4 to 6 hrs of collection by centrifugation & it contains approximately 5.5 x 1010 platelets.

• Single Donor Platelets (SDP) are prepared by platelet aphaeresis machine. One unit of SDP is equivalent to 5 to 10 units of RDP.

Page 5: Platelet Transfusion Afshan

Low platelet count• A slightly lower platelet count will not

usually cause any problems• A very low platelet count, however, can

sometimes be serious• Signs of a low platelet count include

nosebleeds, bleeding gums, heavy periods, bruising and tiny blood spots in the skin or rashes.

Page 6: Platelet Transfusion Afshan

When the patient bleeds??

Surgical bleeding due solely to thrombocytopenia occurs when platelets < 50,000/µL while spontaneous bleeding occurs when platelets < 10,000/µL.

Page 7: Platelet Transfusion Afshan

Platelet Usage in Clinical Practice

• Indications  Platelet transfusion is NOT indicated for all thrombocytopenic patients

Page 8: Platelet Transfusion Afshan

Indications for platelet tx..

Platelet transfusions are traditionally given

– Leukemia– aplastic anemia,– AIDS– hypersplenism,– Sepsis– bone marrow transplant– radiation treatment– organ transplant or surgeries such as

cardiopulmonary bypass.

Page 9: Platelet Transfusion Afshan

Indications:

Prophylactic Therapeutic

Page 10: Platelet Transfusion Afshan

Prophylactic Prophylactic platelet transfusions

reduce morbidity and improves patients’ quality of life but there is no evidence that it reduces mortality 

Page 11: Platelet Transfusion Afshan

Prophylactic Platelet Transfusion

• Thrombocytopenia without any bleeding when the platelet count is < 5 x 109/L (Not applicable for ITP)

• In case of associated sepsis, DIC, fever or Amphotericin B therapy, transfuse at < 10 x 109/L

Page 12: Platelet Transfusion Afshan

Therapeutic 

 Therapeutic platelet transfusions

used to arrest bleeding and reduces both morbidity and mortality 

Page 13: Platelet Transfusion Afshan

Therapeutic Platelet Transfusion

• Intracranial hemorrhage • Severe profuse gum bleeding • Severe menorrhagia. • Emergency Surgery in a patient

with thrombocytopenia with platelets < 30 x 109/L before surgery

Page 14: Platelet Transfusion Afshan

Avoid platelet tx in..• Platelet transfusions should be avoided in

those with TTP because it can worsen neurologic symptoms and acute renal failure, presumably due to creation of new thrombi as the platelets are consumed.

• It should also be avoided in those with heparin-induced thrombocytopenia (HIT) or disseminated intravascular coagulation

Page 15: Platelet Transfusion Afshan

Immune thrombocytopenia.

• Platelet transfusions are generally not recommended

• antibodies destroy platelets, therefore any newly transfused platelets will also be destroyed.

Page 16: Platelet Transfusion Afshan

Cardiopulmonary bypass surgery

Result in destruction of a large proportion of the patient's

platelets and may render the remaining viable platelets to be

dysfunctional. The indications for transfusion in such patients is

controversial.

Page 17: Platelet Transfusion Afshan

Drug-induced platelet dysfunction.

The most common of these is aspirin, and its similar drug class, the NSAIDs. Other antiplatelet drugs are commonly prescribed for patients with acute coronary syndromes.When surgery is undertaken following the administration of these drugs, bleeding can be serious.

Page 18: Platelet Transfusion Afshan

Expected platelet increase after transfusion

Platelet count increase as well as platelet survival after transfusion

is related to the dose of platelets infused and to the patient's body surface area

Page 19: Platelet Transfusion Afshan

• Corrected platelet count increment (CCI) = platelet increment at one hr x BSA (m2) / # platelets infused x 1011

• Expected platelet increase = platelets infused x CCI / BSA (m2)

Page 20: Platelet Transfusion Afshan

• The theoretical value of the CCI is 20,000/μL but clinically, the value is more close to 10,000/μL.

• If the CCI is less than 5,000/μL, patients are said to have "refractoriness" to platelet transfusion.

Page 21: Platelet Transfusion Afshan
Page 22: Platelet Transfusion Afshan

Who can be an apheresis donor?

• at least 17 year of age• in good health• weigh at least 110 pounds• not have taken aspirin or products

containing aspirin within 72 hours prior to donation.

Page 23: Platelet Transfusion Afshan

Before collection…The donor must not take aspirin or

other anti-platelet medications for anywhere from 36 to 72 hours prior to donation. The reason for this is that aspirin can prevent platelets from adhering

Page 24: Platelet Transfusion Afshan

Types of platelet collection???

Page 25: Platelet Transfusion Afshan

Platelet concentrate

• Each unit of platelets separated from donated whole blood is called a "platelet concentrate".

• This greatly increases the risks of the transfusion

Page 26: Platelet Transfusion Afshan

Apheresis • The donor's blood is processed in

a sterile single-use centrifuge, the unwanted components can be returned to the donor safely.

Page 27: Platelet Transfusion Afshan

Soft-spin method(Platelet separation methodology

Soft" spin

platelet-rich plasma

Harder spin

Platelets suspended in a volume of about 50 mL of plasma

Page 28: Platelet Transfusion Afshan

Life Span after Infusion:

Few hrs to maximum 24 hrs. This depends on whether the patient is

bleeding or not.

Page 29: Platelet Transfusion Afshan

Efficacy• One unit of platelet RDP increases

platelet count by approximately 5 x 109/L (i.e. 5000 / mm3).

• SDP is as effective as RDP. SDP is more expensive & its use should be limited to cases of platelet refractoriness & in limiting donor exposure.

Page 30: Platelet Transfusion Afshan

Checking platelet efficacy after tx

• An unconfirmed, but helpful, way to determine whether a patient is recovering from chemotherapy-induced thrombocytopenia is to measure "reticulated" platelets, or young RNA-containing platelets, which signifies that the patient is starting to make new platelets.

Page 31: Platelet Transfusion Afshan

RefractorinessRefractoriness to platelet

transfusion will be defined in this review as a platelet count response to two or more platelet transfusions that is significantly less than expected.

Page 32: Platelet Transfusion Afshan

RefractorinessThis can occur for two reasons:

non-immune causes andimmune causes.

However, becoming refractory to platelets is rare.

Page 33: Platelet Transfusion Afshan

Non-immune causes• High temperature. Platelets are used

up faster if you have a high temperature.

• Antifungal drugs, can lower the platelet count

• Hypersplenism platelets can collect there instead of circulating in the bloodstream.

Page 34: Platelet Transfusion Afshan

Immune causesPlatelets can become less effective

when immune system recognizes the donated platelets as different from own. body then produces antibodies The antibodies attack and destroy the platelets quickly

Page 35: Platelet Transfusion Afshan

Possible side effects • Severe side effects from platelet

transfusions are rare.• The more common side effects include

– itching,– rashes,– a high temperature and shivering

(sometimes referred to as having a 'reaction').

Page 36: Platelet Transfusion Afshan

Risks of platelet transfusions

– Bacterial contamination – Allergic reactions – Febrile reactions – Venous thromboembolism – TRALI

Page 37: Platelet Transfusion Afshan

Side-effects of Platelet transfusion  

PLASMA: 200ml in each adult dose - ABO and other antibodies HTR - plasma proteins allergic reactions, anaphylaxis - passive tx of HLA/granulocyte antibodies TRALI 

Page 38: Platelet Transfusion Afshan

LEUCOCYTES 

HLA antibody formation - non hemolytic febrile reactions  - refractoriness to platelet transfusions 

Page 39: Platelet Transfusion Afshan

PLATELETS (HLA + HPA antigens) •

- HLA antibody stimulation - Refractoriness to tx - HPA immunization, antibody stimulation & rarely refractoriness and even more rarely, in females,

Page 40: Platelet Transfusion Afshan

Management of these side effects

• Leukoreduction• gamma –irradiation• select HLA-compatible donors

Page 41: Platelet Transfusion Afshan